Invokana Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

CANAGLIFLOZIN:Utility for the Treatment of Post-prandial Hypoglycemia Following Gastric By-pass
Condition:   Postprandial Hypoglycemia, Y-en-Roux Gastric By-pass, Canagliflozin Intervention:   Drug: Canagliflozin 300 MG Oral Tablet Sponsor:   Hospital Universitari Vall d'Hebron Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials